Status:
UNKNOWN
Evaluation of Inflammatory Cytokines During COVID-19
Lead Sponsor:
University of Vienna
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.
Detailed Description
In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and micr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age \> 18 years
- Confirmation of acute SARS-CoV2 infection
- Ability to provide informed consent
Exclusion
Key Trial Info
Start Date :
January 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04824495
Start Date
January 7 2021
End Date
December 31 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090